The APPRISE Centre of Research Excellence is developing research to inform Australia’s emergency response to infectious diseases
APPRISE CRE is an Australia-wide network of experts involved in medical, scientific, public health and ethics research. APPRISE is funded by the National Health and Medical Research Council.
Our work impacts both children and adults and focuses on working with populations who are potentially at higher risk of infectious diseases. These communities include Aboriginal and Torres Strait Islander peoples, refugees and other socially vulnerable or disadvantaged groups.
APPRISE CRE works on a range of high-impact infectious diseases
- Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV)
- Middle East Respiratory Coronavirus (MERS-CoV)
- haemorrhagic viruses including Ebola virus (EBOV)
- vector-borne pathogens including arboviruses such as Zika virus
- bacterial diseases such as Meningococcal W disease
- animal pathogens of relevance to humans.
Latest 2018 UPDATE: APPRISE projects for 2018–2019 and the contingency grant on parechovirus have commenced. Project and grant titles can be viewed here.
